Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy
Conditions: Amyloid Cardiomyopathy; Wild Type ATTR Amyloidosis Interventions: Other: Interview Sponsors: Medical University of Graz; Medical University Innsbruck Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis
Conditions: Transthyretin Amyloid Cardiomyopathy (ATTR CM) Interventions: Drug: NNC6019-0001 Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Bronx Transthyretin Amyloid Cardiomyopathy Database
Conditions: Transthyretin Cardiac Amyloidosis; Transthyretin Amyloid Cardiomyopathy Interventions: Diagnostic Test: 99mTc-pyrophosphate Single Photon Emission Computed Tomography Sponsors: Montefiore Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
Conditions: ATTRwt Amyloidosis Sponsors: Paolo Milani Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Affection of Renal and Urinary System in IBD Patients
Conditions: Nephrolithiasis, Glomerulonephritis, Amyloidosis,AKI, CKD, Tubuli Interstitial; Urinary System Disorders in IBD Patients Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
Conditions: AL Amyloidosis Sponsors: IRCCS Policlinico S. Matteo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
Cardiac Amyloidosis in HFpEF Tunisian Patients
Conditions: Cardiac Amyloidosis; Heart Failure With Preserved Ejection Fraction; Echocardiography; CMR; Bone Scintigraphy; TTR Cardiac Amyloidosis; AL Amyloidosis; Prevalence; Diagnosis Sponsors: University Tunis El Manar Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Amylo-shiatsu-acute-chronic
Conditions: Cardiac Amyloidosis Interventions: Other: Targeted Shiatsu Sponsors: Assistance Publique - H ôpitaux de Paris; Association Française Contre l ' Amylose (association of patients and families of patients) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
Conditions: Amyloidosis; Systemic; AL Amyloidosis Interventions: Drug: Daratumumab; Drug: Bortezomib; Drug: Dexamethasone; Drug: Venetoclax Sponsors: Jin Lu, MD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Amyloidosis Incidence in High-Risk Cardiac Device Patients
Conditions: Amyloid; Cardiac Amyloidosis; Amyloidosis Cardiac; Systemic Amyloidosis; AL Amyloidosis; Infiltrative Cardiomyopathy, Amyloid; ATTR Amyloidosis Wild Type Interventions: Procedure: Chest Wall Fat Tissue Collection Sponsors: Midwest Heart& Vascular Specialists Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Validation of Different Diagnostic Modalities in the Detection of Cardiac Amyloidosis Among Patients With " Red Flags "
Conditions: Cardiac Amyloidosis Interventions: Diagnostic Test: CMR Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion
Conditions: Immunoglobulin Light Chain (AL) Amyloidosis Interventions: Drug: ABBV-383 Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Conditions: Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Interventions: Biological: NTLA-2001; Drug: Placebo Sponsors: Intellia Therapeutics; Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Cardiac Amyloidosis Registry of University Hospital Leipzig
Conditions: Cardiac Amyloidosis Interventions: Other: Routine diagnostics; Other: Routine treatment Sponsors: University of Leipzig Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Aortic Stenosis and Cardiac Amyloidosis
Conditions: Cardiac Amyloidosis; Aortic Stenosis Interventions: Drug: Amyloid-specific treatment; Other: No amyloid-specific treatment Sponsors: Medical University of Vienna; Allina Health System; Royal Free Hospital NHS Foundation Trust; Columbia University; Medical University of South Carolina; Laval University; Vilnius University Hospital Santaros Klinikos; Universit é Catholique de Louvain; Wolfson Medical Center; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Trieste Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
